Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanolphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis
- 192 Downloads
Thapsigargin, a hexaoxygenated tetraacylated sesquiterpene lactone, induced irritation of mouse ear and histidine decarboxylase (HDC) activity in mouse skin, but it did not induce ornithine decarboxylase in mouse skin or adhesion of human promyelocytic leukemia (HL-60) cells. Although thapsigargin did not give consistent positive results in a short-term screening system for tumor promoters, it was tested in a two-stage carcinogenesis experiment on mouse skin. The potency of thapsigargin to induce HDC in mouse skin was used to determine the dose in this experiment. Application of 10 μg (17 nmol) thapsigargin induced HDC activity of 139 pmol CO2/mg protein per 60 min. Tumors were found in the skin of 53.5% of the mice treated with DMBA plus 5 μg (8.5 nmol) thapsigargin in week 22, in none of those treated with thapsigargin alone by week 30. One tumor appeared in 1 of 15 mice treated with DMBA alone in week 21. Thapsigargin cannot bind to the phorbol ester receptor in the particulate fraction of mouse skin and so is classified as a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter. It is a new tumor promoter differing in many respects from the well-defined TPA type tumor promoters. Several naturally occurring analogues of thapsigargin, such as thapsigargicin and thapsitranstagin, might also be new non-TPA type tumor promoters, because thapsigargicin and thapsitranstagin induced irritation of mouse ear and HDC activity in mouse skin.
Key wordsThapsigargin Non-TPA type tumor promoter HDC Hexaoxygenated tetraacylated sesquiterpene lactone Histamine releasing activity
Unable to display preview. Download preview PDF.
- Boutwell RK (1978) Biochemical mechanism of tumor promotion: In: Slaga TJ, Sivak A, Boutwell RK (eds) Carcinogenesis — a comprehensive survey, vol 2. Raven Press, New York, pp 49–58Google Scholar
- Christensen SB, Larsen IK, Rasmussen U (1982) Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia garganica. X-Ray analysis of the 7,11-epoxide of thapsigargin. J Org Chem 47:649–652Google Scholar
- Christensen SB, Norup E, Rasmussen U (1983) Chemistry and structure-activity relationship of the histamine secretagogue thapsigargin and related compounds. In: Krogrgaard-Larsen P, Christensen SB, Kofod H (eds) Natural products and drug development. Munksgaard, Copenhagen, pp 17–28Google Scholar
- Fujiki H, Sugimura T (1983) New potent tumor promoters: teleocidin, lyngbyatoxin A and aplysiatoxin. In: Slaga T, Montesano R (eds) Cancer surveys, vol 2. Oxford University Press, London, pp 539–556Google Scholar
- Fujiki H, Suganuma M, Tahira T, Yoshioka A, Nakayasu M, Endo Y, Shudo K, Takayama S, Moore RE, Sugimura T (1984) New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. In: Fujiki H, Hecker E, Moore RE, Sugimura T, Weinstein IB (eds) Cellular interactions by environmental tumor promoters. Jpn Sci Soc Press Tokyo/VNU Science Press, Utrecht, pp 37–45Google Scholar
- Hecker E (1971) Isolation and characterization of the cocarcinogenic principles from croton oil. In: Busch H (ed) Methods in cancer research, vol 6. Academic Press, New York, London, pp 439–484Google Scholar
- Ohuchi K, Watanabe M, Yoshizawa K, Tsurufuji S, Fujiki H, Suganuma M, Sugimura T, Levine L (1985) Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol-13-acetate (TPA)-type and non-TPA type tumor promoters in macrophages and its inhibition by cycloheximide. Biochem Biophys Acta 834:42–47PubMedGoogle Scholar